Literature DB >> 17461801

Pigmented hypertrichotic dermatosis and insulin dependent diabetes: manifestations of a unique genetic disorder?

Julie Prendiville1, Maureen Rogers, Alex Kan, Fernando de Castro, Melanie Wong, Anne Junker, Charlie Becknell, Kirk Schultz.   

Abstract

A novel pigmented dermatosis was observed in four unrelated boys, three of whom had insulin-dependent diabetes. Three patients were the offspring of consanguineous parents. All four boys had pigmented hypertrichotic patches or induration on the upper inner thighs, with variable involvement of the genitalia, trunk, and limbs. Two boys had episcleritis and orbital proptosis with similar facies and musculoskeletal abnormalities including clinodactyly, flat feet, and short stature. One child had paraaortic and inguinal lymphadenopathy and three patients had an enlarged liver and spleen. A large, swollen pancreas was observed on ultrasound imaging in one patient with insulin dependent diabetes who also had echocardiographic evidence of pericardial inflammation. Three boys had elevated laboratory markers of inflammation. Biopsy specimens from the skin and orbit showed a chronic inflammatory cell infiltrate composed of polyclonal lymphocytes, histiocytes, and plasma cells; fibrosis was observed in two patients, one of whom had previously received radiation therapy to the orbit. Two boys responded to treatment with subcutaneous interferon-alpha, combined with a short course of oral prednisone in the child without diabetes. We believe these inflammatory pigmented skin lesions represent a unique dermatosis associated with diabetes mellitus and systemic disease. The pathogenesis is unknown. The presence of consanguinity in three of four families, and similar dysmorphic features in two boys, suggest a genetic disorder, possibly with autosomal recessive inheritance.

Entities:  

Mesh:

Year:  2007        PMID: 17461801     DOI: 10.1111/j.1525-1470.2007.00352.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  7 in total

1.  Accelerated coronary atherosclerosis and H syndrome.

Authors:  Ravindranath K Shankarappa; Rajiv Ananthakrishna; Ravi S Math; Sachin Dhareppa Yalagudri; Satish Karur; Ramesh Dwarakaprasad; Manjunath C Nanjappa; Vered Molho-Pessach
Journal:  BMJ Case Rep       Date:  2011-10-04

2.  The H syndrome is caused by mutations in the nucleoside transporter hENT3.

Authors:  Vered Molho-Pessach; Israela Lerer; Dvorah Abeliovich; Ziad Agha; Abdulasalam Abu Libdeh; Valentina Broshtilova; Orly Elpeleg; Abraham Zlotogorski
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

Review 3.  A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.

Authors:  Sadaf Noavar; Samira Behroozi; Taraneh Tatarcheh; Farshid Parvini; Majid Foroutan; Hossein Fahimi
Journal:  BMC Med Genet       Date:  2019-08-29       Impact factor: 2.103

4.  Adult stem cell deficits drive Slc29a3 disorders in mice.

Authors:  Sreenath Nair; Anne M Strohecker; Avinash K Persaud; Bhawana Bissa; Shanmugam Muruganandan; Craig McElroy; Rakesh Pathak; Michelle Williams; Radhika Raj; Amal Kaddoumi; Alex Sparreboom; Aaron M Beedle; Rajgopal Govindarajan
Journal:  Nat Commun       Date:  2019-07-03       Impact factor: 14.919

Review 5.  Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder.

Authors:  Özge Besci; Kashyap Amratlal Patel; Gizem Yıldız; Özlem Tüfekçi; Kübra Yüksek Acinikli; İbrahim Mert Erbaş; Ayhan Abacı; Ece Böber; Meral Torun Bayram; Şebnem Yılmaz; Korcan Demir
Journal:  Hormones (Athens)       Date:  2022-03-14       Impact factor: 3.419

Review 6.  Review of the current literature on H syndrome treatment.

Authors:  Kimia Saleh Anaraki; Sepehr Khosravi; Elham Behrangi; Afsaneh Sadeghzadeh-Bazargan; Azadeh Goodarzi
Journal:  J Family Med Prim Care       Date:  2022-03-10

7.  A Tale of H Syndrome with Typical Radiographic Findings.

Authors:  Praneet Pradeep Awake; Lakshmi Chandravathi Penmetcha; Anil Fonseca; Prasad Prabhakar Jawalkar
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.